KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Guardant Health (GH) EBIAT (2017 - 2025)

Historic EBIAT for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$92.7 million.

  • Guardant Health's EBIAT rose 1394.75% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 2217.38%. This contributed to the annual value of -$436.4 million for FY2024, which is 898.45% up from last year.
  • Per Guardant Health's latest filing, its EBIAT stood at -$92.7 million for Q3 2025, which was up 1394.75% from -$99.9 million recorded in Q2 2025.
  • Guardant Health's 5-year EBIAT high stood at -$72.3 million for Q4 2021, and its period low was -$229.4 million during Q2 2022.
  • Over the past 5 years, Guardant Health's median EBIAT value was -$107.5 million (recorded in 2021), while the average stood at -$118.1 million.
  • As far as peak fluctuations go, Guardant Health's EBIAT crashed by 23729.62% in 2021, and later surged by 6828.21% in 2023.
  • Over the past 5 years, Guardant Health's EBIAT (Quarter) stood at -$72.3 million in 2021, then crashed by 93.52% to -$139.9 million in 2022, then crashed by 33.67% to -$187.0 million in 2023, then soared by 40.65% to -$111.0 million in 2024, then grew by 16.47% to -$92.7 million in 2025.
  • Its EBIAT stands at -$92.7 million for Q3 2025, versus -$99.9 million for Q2 2025 and -$95.2 million for Q1 2025.